This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an acute episo…

Bipolar Disorder Type I With Mania or Mania With Mixed Features

~Estimated

~$10 – $7,500

Bristol-Myers SquibbNCT06951711

Phase 3

A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania With Mixed Features in Bipolar-I Disorder (BALSAM-3)

This is a phase 3, open-label extension study to assess the long-term safety of KarXT for the treatment of mania or mania with mixed features in Bipolar-I diso…

Bipolar Disorder Type I With Mania

~Estimated

~$10 – $7,500

Bristol-Myers SquibbNCT06929273